SOX2 utilizes FOXA1 as a heteromeric transcriptional partner to drive proliferation in therapy-resistant prostate cancer.
SOX2 利用 FOXA1 作为异源转录伙伴来驱动耐药性前列腺癌的增殖
期刊:
影响因子:
doi:10.1101/2025.07.18.664790
Phoenix John T, Budreika Audris, Schmeck Devin A, Kostlan Raymond J, Ferrari Marina G, Young Kristen S, Rogers Charles S, Deegan Carleen D, Bienko Marcus W, Bergom Hannah E, Boytim Ella, Brown Ryan M, Walewicz Julia A, Bhagi Shreya K, Ellis Leigh, Antonarakis Emmanuel S, Drake Justin M, Bawa Pushpinder S, Vellky Jordan E, Williams Anthony, Rezine Natalie M, Rennhack Jonathan P, Fanning Sean W, Hwang Justin H, Szmulewitz Russell Z, Vander Griend Donald J, Kregel Steven
